💨 Abstract
Houston-based Salarius Pharmaceuticals, Inc. (SLRX) reported a second-quarter loss of $958,000, equivalent to 45 cents per share. The article was generated by Automated Insights using data from Zacks Investment Research.
Courtesy: WTOP Staff
Suggested
¿La última fugaz tendencia de belleza en TikTok? Verse cansada como Jenna Ortega -
Parents and child killed when tree falls on car amid heavy rain, flooding in Tennessee -
DC home prices still rising, but they’re falling in 1 in 5 metro areas now -
3 people were killed, including a child, when a tree fell on their car amid heavy rain in Tennessee, official says -
Migrant boat capsizes off Italy and leaves at least 20 people dead, UN says -
Neonode: Q2 Earnings Snapshot -
Photos of taxi drivers in Zimbabwe showing off team colors for the Premier League soccer season -
Trump está reforzando su control sobre la economía, tomando una página del libro de China -
Bills running back James Cook ends contract standoff by agreeing to four-year, $48 million deal -
Star Equity: Q2 Earnings Snapshot -